ARGX vs ONC
argenx SE and BeOne Medicines AG, both Healthcare
argenx SE is the larger company at $56B against $29B. Over the past year ARGX returned +12% against +5.9% for ONC.
| Figure | ARGX | ONC |
|---|---|---|
| Last close | $825 | $354 |
| Market cap | $56B | $29B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 42.2 | n/a |
| 1-year return | +12% | +5.9% |
| 5-year return | +156% | -4.0% |
| RyuScoresector-relative, 1–10 | 11/100 | n/a |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
argenx SE
Revenue of $2.5B in H2 2025, net income $877M.
BeOne Medicines AG
Open these two in the interactive comparison to add more names, change the period or see the correlation.